A digital manufactured microfluidic platform for flexible construction of 3D co-culture tumor model with spatiotemporal resolution
Source abstract
Abstract
Abstract The specific spatiotemporal distribution of diverse components in tumor microenvironment plays a crucial role in the cancer progression. In vitro three-dimensional (3D) tumor models with polydimethylsiloxane (PDMS) based microfluidic platform have been applied as useful tool to conduct studies from cancer biology to drug screening. However, PDMS has not been welcomed as a standardized commercial application for preclinical screening due to inherent limitations in scale-up production and molecule absorption. Here, we present a novel microfluidic platform to flexibly construct 3D co-culture models with spatiotemporal resolution by using multiple digital manufacturing technologies. The platform, which consist of reduplicative microfluidic chips, is made of biocompatible poly methyl methacrylate by fast laser cutting. Each replica includes a simple microfluidic chamber without internal structures which can be flexibly post-fabricated according to various research requirements. Digital light processing based 3D bioprinting was used to pattern fine hydrogel structures for post-fabrication on-chip. By multi-step bioprinting and automatic image alignment, we show that this approach provides sufficient design flexibility to construct 3D co-culture tumor model with spatiotemporal resolution to replicate microarchitecture of tumor microtissue in situ. And the tumor model has the potential to mimic tumor biology behaviors which can be used for mechanism study and drug test. Our microengineered tumor model may serve as an enabling tool to recapitulate pathophysiological complexity of tumor, and to systematically examine the contribution of the tumor microenvironment to the cancer progression. The proposed strategy can also be applied to help engineer diverse meaningful in vitro models for extensive biomedical applications, from physiology and disease study to therapy evaluation.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Innovative Microfluidic and Catalytic Techniques Innovation · Microfluidic and Bio-sensing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer10.1016/j.addr.2013.11.011 ↗
2. Effect of stromal cells in tumor microenvironment on metastasis initiation10.7150/ijbs.25720 ↗
3. 3D cell culture systems: tumor application, advantages, and disadvantages10.3390/ijms222212200 ↗
4. Multi-parametric hydrogels support 3D in vitro bioengineered microenvironment models of tumour angiogenesis10.1016/j.biomaterials.2015.02.124 ↗
5. Recapitulating spatiotemporal tumor heterogeneity in vitro through engineered breast cancer microtissues10.1016/j.actbio.2018.04.028 ↗
6. Advanced biomaterials and microengineering technologies to recapitulate the stepwise process of cancer metastasis10.1016/j.biomaterials.2017.04.017 ↗
7. Tumor spheroid-on-a-chip: a standardized microfluidic culture platform for investigating tumor angiogenesis10.1039/C9LC00140A ↗
8. An integrated biomimetic array chip for high-throughput co-culture of liver and tumor microtissues for advanced anticancer bioactivity screening10.1039/D0LC00288G ↗
9. Engineering neurovascular organoids with 3D printed microfluidic chips10.1039/D1LC00535A ↗
10. Microfluidic 3D cell culture: from tools to tissue models10.1016/j.copbio.2015.05.002 ↗
11. Microfluidic-based platforms for cell-to-cell communication studies10.1088/1758-5090/ad1116 ↗
12. A multilayered blood vessel/tumor tissue chip to investigate T cell infiltration into solid tumor tissues10.1039/D1LC00182E ↗
13. Reconfigurable open microfluidics for studying the spatiotemporal dynamics of paracrine signalling10.1038/s41551-019-0421-4 ↗
14. Is it time for reviewer 3 to request human organ chip experiments instead of animal validation studies?10.1002/advs.202002030 ↗
15. Roles of macrophages in tumor development: a spatiotemporal perspective10.1038/s41423-023-01061-6 ↗
16. Interstitial flow regulates the angiogenic response and phenotype of endothelial cells in a 3D culture model10.1039/C6LC00910G ↗
17. Microfluidic Gut-liver chip for reproducing the first pass metabolism10.1007/s10544-016-0143-2 ↗
18. Small molecule absorption by PDMS in the context of drug response bioassays10.1016/j.bbrc.2016.11.062 ↗
19. Multiple myeloma cell drug responses differ in thermoplastic vs PDMS microfluidic devices10.1021/acs.analchem.7b02351 ↗
20. Digital manufacturing for accelerating organ-on-a-chip dissemination and electrochemical biosensing integration10.1039/D2LC00499B ↗
21. Digital manufacturing for microfluidics10.1146/annurev-bioeng-092618-020341 ↗
22. Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment10.1126/sciadv.abi9119 ↗
23. Microfluidics-enabled multimaterial maskless stereolithographic bioprinting10.1002/adma.201800242 ↗
24. Tunable resins with PDMS-like elastic modulus for stereolithographic 3D-printing of multimaterial microfluidic actuators10.1039/D3LC00529A ↗
25. Cell culture on MEMS platforms: a review10.3390/ijms10125411 ↗
26. Construction of a three-dimensional urothelium on-chip with barrier function based on urinary flow microenvironment10.1088/1758-5090/acc4ec ↗
27. Tumor-induced local and systemic impact on blood vessel function10.1155/2015/418290 ↗
28. Pumpless microfluidic devices for generating healthy and diseased endothelia10.1039/C9LC00446G ↗
29. Endothelial cells as tools to model tissue microenvironment in hypoxia-dependent pathologies10.3390/ijms22020520 ↗
30. Tumor angiogenesis and vascular normalization: alternative therapeutic targets10.1007/s10456-017-9562-9 ↗
31. Multivascular networks and functional intravascular topologies within biocompatible hydrogels10.1126/science.aav9750 ↗
32. Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span10.1126/science.abc8479 ↗
33. Bevacizumab (Avastin®) in cancer treatment: a review of 15 years of clinical experience and future outlook10.1016/j.ctrv.2020.102017 ↗
34. Human ocular angiogenesis-inspired vascular models on an injection-molded microfluidic chip10.1002/adhm.201900328 ↗
35. Chronic inflammation and cytokines in the tumor microenvironment10.1155/2014/149185 ↗
36. Tumor microenvironment as a therapeutic target in cancer10.1016/j.pharmthera.2020.107753 ↗
37. Bioprinting the cancer microenvironment10.1021/acsbiomaterials.6b00246 ↗